Table 1 Association between preoperative serum CA125 and clinicopathological factors
From: Preoperative serum CA125: a useful marker for surgical management of endometrial cancer
Characteristic | No of patients | Mean rank of CA125 | P value |
|---|---|---|---|
Age | Â | Â | Â |
 ≤50 | 253 | 530.87 |  |
 >50 | 742 | 486.79 | 0.04 |
Menopause | Â | Â | Â |
 No | 354 | 527.53 |  |
 Yes | 641 | 481.69 | 0.02 |
BMI (kg/m2) | Â | Â | Â |
 <25 | 501 | 517.25 |  |
 ≥25 | 494 | 478.47 | 0.03 |
FIGO stage | Â | Â | Â |
 I | 769 | 425.27 |  |
 II | 85 | 642.04 |  |
 III | 116 | 785.00 |  |
 IV | 25 | 913.76 | 0.00 |
Histology type | Â | Â | Â |
 Endometrioid cancer | 955 | 495.08 |  |
 Non endometrioid cancer | 40 | 567.83 | 0.12 |
Histology grade | Â | Â | Â |
 1 | 495 | 447.52 |  |
 2 | 367 | 533.45 |  |
 3 | 133 | 588.06 | 0.00 |
Lymph node metastasis | Â | Â | Â |
 no | 895 | 466.82 |  |
 yes | 100 | 777.04 | 0.00 |
Adnexal involvement | Â | Â | Â |
 No | 931 | 473.39 |  |
 yes | 64 | 856.01 | 0.00 |
Distance metastasis | Â | Â | Â |
 no | 958 | 482.37 |  |
 yes | 37 | 885.90 | 0.00 |
myometrial invasion | Â | Â | Â |
 ≤1/2 | 810 | 456.38 |  |
 >1/2 | 185 | 674.41 | 0.00 |
Cervical stromal invasion | Â | Â | Â |
 No | 859 | 460.02 |  |
 yes | 136 | 737.92 | 0.00 |
Positive peritoneal cytology | Â | Â | Â |
 No | 964 | 485.19 |  |
 yes | 31 | 909.97 | 0.00 |